Form NPORT-P - Monthly Portfolio Investments Report on Form N-PORT (Public):
SEC Accession No. 0001145549-23-007923
Filing Date
2023-02-22
Accepted
2023-02-22 12:28:51
Documents
2
Period of Report
2022-12-30

Document Format Files

Seq Description Document Type Size
1 primary_doc.html NPORT-P  
1 primary_doc.xml NPORT-P 31709
2 ETF VI (3/31) N-PORT PART F etf6edgar.htm NPORT-EX 667048
  Complete submission text file 0001145549-23-007923.txt   700240

Series and Classes/Contracts Information:

Existing
  Status Name Ticker Symbol
CIK 0001552740      
Series S000053945   First Trust Nasdaq Pharmaceuticals ETF
Class/Contract C000169747   First Trust Nasdaq Pharmaceuticals ETF FTXH
Mailing Address 120 EAST LIBERTY DRIVE, SUITE 400 WHEATON IL 60187
Business Address 120 EAST LIBERTY DRIVE, SUITE 400 WHEATON IL 60187 630-765-8000
FIRST TRUST EXCHANGE-TRADED FUND VI (Filer) CIK: 0001552740 (see all company filings)

EIN.: 000000000 | State of Incorp.: MA
Type: NPORT-P | Act: 40 | File No.: 811-22717 | Film No.: 23651933